drugset / Trial / NCT00487578

Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction

NCT00487578 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.

Timeline

Start
2006-10
Primary completion
2009-10
Completion
2009-10

Outcome

Outcome not reported

Stopped (Enrollment): “Terminated October 2009 (in 4th year) due to low enrollment and anticipated drug expiration November 2009.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator naratriptan Small molecule 2.5 mg —

Indications

No indication recorded.